I'd be interested in hearing what the fundamental prospects are for this company. Do they have any proprietary technologies that might be attractive to an acquiror with a greater distribution? Is their distribution reaching critical mass.
Clearly their float and capitalization will be a hinderence to greater valuations. They are EBITDA positive now, that should be a plus toward ongoing R&D and S&M.